Arcutis Director Sells $121,000 Amid ZORYVE Revenue Surge
A biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
We identify safer crypto choices for newcomers, covering safety features, liquidity signals, and a starter framework.
18,936 articlesA biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
Runlayer closed a $30 million Series A led by FELICIS with Khosla Ventures joining, bringing total funding to $42 mil...
Stocks and oil prices moved on new headlines as Tehran sent mixed signals on UN inspections while Washington kept pre...
Bitcoin’s network activity is rising toward multi-year highs even as BTC trades beneath its all-time high, fueled by ...
Berkshire Hathaway's Greg Abel recently bought Macy's stock, sparking questions about value and strategy. This in-dep...
The GRID fund has surged about 23% in 2026, outpacing the traditional utilities ETF XLU as AI-enabled grid modernizat...
NVIDIA's CEO hints that the next wave of wealth could come from skilled trades like plumbing and electrical work, pro...
The crypto market today, june is marked by a broad selloff across major tokens as inflation concerns rise and risk ap...
Starting with $1,000, you can anchor a tech-forward portfolio on three core players. This guide explains why these co...
When tragedy hits a family, money becomes both a tool and a stressor. This article explores practical steps to stabil...
SpaceX captured attention with its IPO buzz, but jumping in right away can backfire. This guide explains why waiting ...
SpaceX made waves with its IPO, and investors now wonder how to gain exposure without a single stock gamble. This gui...